Opendoor Technologies Holds After Earnings Reset: Risks Opendoor shows operational reset with higher weekly purchases and cost cuts, but earnings remain deeply negative; analysts keep a Hold with balanced risk versus no proven durable profitability. 2026년 04월 17일 English
Hims and Hers Health Buy – Near Term Peptide Catalyst Boost Hims and Hers is a Buy as FDA review of compounded peptide rules may lift demand; revenue and gross margins are strong, though operating income is still falling. 2026년 04월 17일 English
Samsung Electro-Mechanics Stock Hold Decision: Valuation Risk Samsung Electro-Mechanics has strong AI substrate and MLCC demand with improving margins, but valuation and a near-52-week high price limit upside, so the author rates it Hold. 2026년 04월 16일 English
